BioSpace News Archive

It was no roll of the dice that brought Dr. Selim Koseoglu to Las Vegas.

Nearly six percent of urinary tract infections analyzed by a California emergency department were caused by drug-resistant bacteria in a one-year study period, according to new research in Annals of Emergency Medicine.

Seq2Know is offering Familial Hypercholesterolemia (FH) testing.

Mr. Rich Gaspari completed the asset purchase buyout for an undisclosed amount of Mr. Jared Wheat’s co-ownership of Gaspari Nutrition Inc., a Georgia based dietary supplement company.

In the midst of the greatest refugee crisis in world history, with 70 million people forcibly displaced from their homes due to violence and persecution, Bethany Global, a subsidiary of Bethany Christian Services, has formed a working agreement with the United Nations High Commission on Refugees to provide mental health and social services to Sudanese refugees in Gambella, Ethiopia.

Massachusetts General Hospital (MGH) and ideas42, a nonprofit behavioral design lab, today announced a new research collaboration aimed at supporting patients in emergency care seeking treatment for Opioid Use Disorder (OUD).

WALL, N.J.--(BUSINESS WIRE)-- General Technical Services, LLC (GTS, LLC) announced today that it has been awarded a $9.97 million task order to provide Scientific, Engineering and Analysis Support (SEAS) for research at experimental facilities located at Adelphi Laboratory Center (ALC), MD and other sites where researchers from the Army Research Laboratory (ARL) are conducting experiments.

The Xu Laboratory at the iHuman Institute of ShanghaiTech University has deciphered the high-resolution crystal structure of the first human Frizzled receptor.

The Centers for Medicare & Medicaid Services (CMS) has selected Maxim Healthcare Services as a Care Transformation Organization (CTO) for the Maryland Primary Care Program (MDPCP) beginning in January 2019.

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of its Clinical Grade Non-Transfusable products to researchers and clinicians developing studies related to transplantation, cell therapy, regenerative medicine, investigational new drug development and medical devices in preclinical and clinical phases.